VEGFA and liver cancer: This study also found that the levels of HIF1α and VEGF in serum of the two groups of patients were significantly decreased after treatment, suggesting that hepatic arterial chemoembolization combined with radiofrequency ablation has a significant effect on liver function and immune function in patients with liver cancer and may affect the abnormal levels of HIF1α and VEGF.